Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02129712 · ClinicalTrials.gov registry record · NA
Neuroplasticity-Based Cognitive Remediation for Pediatric Brain Tumor Survivors
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT02129712 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 40 participants.
The verdict
NCT02129712, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This research will leverage novel pilot research conducted by the investigators to take important first steps in addressing neurocognitive late effects by intervening early, during treatment, with a promising computerized cognitive remediation program to prevent the downward trajectory of neurocognitive function experienced by pediatric brain tumor survivors. Specifically, we propose to test the feasibility, acceptability, and initial proof of concept of a neuroplasticity-based adaptive cognitive training program (Cogmed) to train working memory (WM) and attention in newly diagnosed youth with a brain tumor. Further, we will test the feasibility of using this intervention in a true prospective design beginning pre-surgery to examine the effects of this intervention in deflecting the downward trajectory of cognitive function in children with brain tumors during treatment. We will also use functional neuroimaging (near infrared spectroscopy - "NIRS") to examine the effects of this program on brain activation in frontal regions that are affected by treatment. Findings from this pilot study will inform the development of a large multi-site randomized efficacy trial to test an individualized cognitive training program. Aim 1. To test the feasibility and acceptability of enrolling youth (7 to 16 years-old) with newly diagnosed brain tumors at time of diagnosis, following patients for 10 weeks, delivering the Cogmed computer-based training program in a randomized trial at 10-weeks post-diagnosis, and following patients to 1 year post-diagnosis. Aim 2. To test the initial acceptability and efficacy of the Cogmed training program on cognitive function in newly diagnosed pediatric brain tumor patients.
Interventions
- BEHAVIORAL Cognitive training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-02-01 |
| Est. Completion | 2017-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02129712
The ClinicalTrials.gov registry entry for NCT02129712 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive training is the first listed.
NCT02129712 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02129712 about?
NCT02129712 is a clinical study titled "Neuroplasticity-Based Cognitive Remediation for Pediatric Brain Tumor Survivors". This research will leverage novel pilot research conducted by the investigators to take important first steps in addressing neurocognitive late effects by intervening early, during treatment, with a promising computerized cognitive remediation program to prevent the downward trajectory of neurocogni...
What is the current status of trial NCT02129712?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2014-02-01. Estimated completion is 2017-12-31.
What interventions are being tested in trial NCT02129712?
The interventions under investigation include: Cognitive training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02129712?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.